← FDA DRUG APPROVALS

FDA NDA · NDA019931

SODIUM SULFACETAMIDE

Sponsor: BAUSCH

APPLICATION
NDA019931
TYPE
NDA
ORIGINAL APPROVAL
1996-12-23
LATEST ACTION
2016-02-16
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

KLARON · ReferencePrescription
SULFACETAMIDE SODIUM 10% · LOTION · TOPICAL

Approval history

2016-02-16Manufacturing (CMC) · Supplement 24 · standardAP
2015-10-27Manufacturing (CMC) · Supplement 23 · standardAP
2014-12-05Manufacturing (CMC) · Supplement 22 · standardAP
2010-07-02Labeling · Supplement 19 · unknownLetterAP
2003-02-21Manufacturing (CMC) · Supplement 8 · standardLabelAP
2002-10-09Manufacturing (CMC) · Supplement 6 · standardAP
2002-10-09Manufacturing (CMC) · Supplement 7 · standardAP
2002-09-12Manufacturing (CMC) · Supplement 4 · standardAP
2002-09-12Manufacturing (CMC) · Supplement 5 · standardAP
2002-03-26Manufacturing (CMC) · Supplement 3 · standardAP
1999-06-15Manufacturing (CMC) · Supplement 1 · standardAP
1996-12-23Type 3 - New Dosage Form · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →